New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel: Fact Sheet for Healthcare Providers | NLM

Disaster Information Management Research Center | NLM

New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel: Fact Sheet for Healthcare Providers

02/29/2020 12:00 AM EST

Source: U.S. Food and Drug Administration (FDA). Published: 2/29/2020. This three-page fact sheet informs healthcare providers of the significant known and potential risks and benefits of the emergency use of the New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel. The New York SARS-CoV-2 Real-time RT-PCR Diagnostic Panel is authorized for use on respiratory specimens from individuals who meet the Centers for Disease Control and Prevention (CDC) coronavirus disease 2019 (COVID-19) clinical and/or epidemiological criteria. (PDF)